Search Results - "Matucci, A."

Severe Asthma and Biologics: Managing Complex Patients by Matucci, A, Micheletto, C, Vultaggio, A

“…Bronchial asthma is a chronic inflammatory disease of the respiratory tract that varies in terms of clinical presentations (phenotypes) and distinct underlying…”
Get full text

EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders by Boyman, O., Kaegi, C., Akdis, M., Bavbek, S., Bossios, A., Chatzipetrou, A., Eiwegger, T., Firinu, D., Harr, T., Knol, E., Matucci, A., Palomares, O., Schmidt‐Weber, C., Simon, H.‐U., Steiner, U. C., Vultaggio, A., Akdis, C. A., Spertini, F.

“…Biologic agents (also termed biologicals or biologics) are therapeutics that are synthesized by living organisms and directed against a specific determinant,…”
Get full text

Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions by Vultaggio, A, Matucci, A, Nencini, F, Pratesi, S, Parronchi, P, Rossi, O, Romagnani, S, Maggi, E

“…To cite this article: Vultaggio A, Matucci A, Nencini F, Pratesi S, Parronchi P, Rossi O, Romagnani S, Maggi E. Anti-infliximab IgE and non-IgE antibodies and…”
Get full text

Isolation and characterization of an atypical Mycoplasma gallisepticum strain showing a new mgc2 variant by Matucci, A., Stefani, E., Tondo, A., Righetti, V., Bottinelli, M., Gavazzi, L., Merenda, M., Catania, S.

“…Mycoplasma gallisepticum (MG) is an important pathogen of the poultry industry able to cause chronic respiratory disease in chickens and infectious sinusitis…”
Get full text

Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature by Ricci, S., Abu-Rumeileh, S., Campagna, N., Barbati, F., Stagi, S., Canessa, C., Lodi, L., Palterer, B., Maggi, L., Matucci, A., Vultaggio, A., Annunziato, F., Azzari, C.

“…We report the case of a patient with common variable immunodeficiency (CVID) presenting with short stature and treated with recombinant human growth hormone…”
Get full text

Factors reducing omalizumab response in severe asthma by Sposato, B., Scalese, M., Milanese, M., Masieri, S., Cavaliere, C., Latorre, M., Scichilone, N., Matucci, A., Vultaggio, A., Ricci, A., Cresti, A., Santus, P., Perrella, A., Paggiaro, P.L.

“…Despite adding Omalizumab to conventional therapy, several severe asthmatics still show poor disease control. We investigated the factors that may affect a…”
Get full text

IgG4 anti‐infliximab in treated patients: Clinical impact and temporal evolution by Vultaggio, A., Nencini, F., Carraresi, A., Pratesi, S., Movérare, R., Eriksson, C., Venemalm, L., Maggi, E., Matucci, A.

“…Background Infliximab (IFX) carries potential risk of immunogenicity with the production of anti‐drug antibodies (ADA). ADA may belong to different isotypes…”
Get full text

Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group by Jolles, S., Sánchez‐Ramón, S., Quinti, I., Soler‐Palacín, P., Agostini, C., Florkin, B., Couderc, L.‐J., Brodszki, N., Jones, A., Longhurst, H., Warnatz, K., Haerynck, F., Matucci, A., de Vries, E.

“…Summary Many patients with primary immunodeficiency (PID) who have antibody deficiency develop progressive lung disease due to underlying subclinical infection…”
Get full text

Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab by Matucci, A., Pratesi, S., Petroni, G., Nencini, F., Virgili, G., Milla, M., Maggi, E., Vultaggio, A.

“…Summary Background The administration of biological agents is potentially affected by IgE‐mediated infusion reactions. Objective The aim of the study was to…”
Get full text

Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions by Vultaggio, A., Petroni, G., Pratesi, S., Nencini, F., Cammelli, D., Milla, M., Prignano, F., Annese, V., Romagnani, S., Maggi, E., Matucci, A.

“…Summary Antibodies recognizing infliximab (IFX) may develop in a proportion of treated patients, leading to loss of response or hypersensitivity reactions…”
Get full text

Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA by Bormioli, S, Vultaggio, A, Nencini, F, Comin, C E, Bercich, L, Bezzi, M, Vivarelli, E, Calosi, L, Chiccoli, F, Matucci, A

Get full text

Effects of omalizumab in severe asthmatics across ages: A real life Italian experience by Sposato, B, Scalese, M, Latorre, M, Scichilone, N, Matucci, A, Milanese, M, Masieri, S, Rolla, G, Steinhilber, G, Rosati, Y, Vultaggio, A, Folletti, I, Baglioni, S, Bargagli, E, Di Tomassi, M, Pio, R, Pio, A, Maccari, U, Maggiorelli, C, Migliorini, M.G, Vignale, L, Pulerà, N, Carpagnano, G.E, Foschino Barbaro, M.P, Perrella, A, Paggiaro, P.L

“…Abstract Background This retrospective study aimed at evaluating long-term effects of Omalizumab in elderly asthmatics in a real-life setting. Methods 105…”
Get full text

Immunoglobulin replacement therapy for yellow nail syndrome by Lo Conte, C., Allegrini, C., Matucci, A., Bartolucci, M., Rosi, E., Camiciottoli, G., Amendola, M., Pistolesi, M., Bargagli, E.

Get full text

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group by Concolino, D., Amico, L., Cappellini, M.D., Cassinerio, E., Conti, M., Donati, M.A., Falvo, F., Fiumara, A., Maccarone, M., Manna, R., Matucci, A., Musumeci, M.B., Nicoletti, A., Nisticò, R., Papadia, F., Parini, R., Peluso, D., Pensabene, L., Pisani, A., Pistone, G., Rigoldi, M., Romani, I., Tenuta, M., Torti, G., Veroux, M., Zachara, E.

“…Fabry disease (FD) [OMIM 301500] is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal enzyme alpha-galactosidase A, resulting in…”
Get full text

Influence of total serum IgE levels on the in vitro detection of β-lactams-specific IgE antibodies by Vultaggio, A., Matucci, A., Virgili, G., Rossi, O., Filì, L., Parronchi, P., Romagnani, S., Maggi, E.

“…Summary Background Allergic reactions to β‐lactams are a frequent cause of adverse drug reactions; the diagnosis is based on history, clinical examination,…”
Get full text

Cloning, expression, and antigenic characterization of recombinant protein of Mycoplasma gallisepticum expressed in Escherichia coli by Rocha, T. S., Tramuta, C., Catania, S., Matucci, A., Giuffrida, M. G., Baro, C., Profiti, M., Bertolotti, L., Rosati, S.

“…Mycoplasma gallisepticum (MG) is a member of the most important avian mycoplasmas, causing chronic respiratory disease in chickens and leading to important…”
Get full text

Autoimmune hepatitis in a patient affected by neuromyelitis optica: A new association by Romanelli, R.G, Fassio, F, Cappelli, F, Giudizi, M.G, Cecioni, I, Matucci, A, Castiglione, F, Tarquini, R, Almerigogna, F

Get full text

Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma by Sposato, B, Scalese, M, Milanese, M, Masieri, S, Cavaliere, C, Latorre, M, Scichilone, N, Matucci, A, Vultaggio, A, Ricci, A, Cresti, A, Paggiaro, P L

Get full text

Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function by Capitani, N, Ariani, F, Amedei, A, Pezzicoli, A, Matucci, A, Vultaggio, A, Troilo, A, Renieri, A, Baldari, C T, D' Elios, M M

“…Common variable immunodeficiency (CVID) is a primary immune disorder characterized by impaired antibody production, which is in many instances secondary to…”
Get more information

P.16.14 LOSS OF EFFICACY AND ADVERSE DRUG REACTIONS DURING INFLIXIMAB THERAPY IN IBD PATIENTS ARE RELATED TO THE APPEARANCE OF ANTI-INFLIXIMAB ANTIBODIES by Settesoldi, A, Giannotta, M, Genise, S, Santini, A, Bagnoli, S, Milla, M, Annese, V, Matucci, A, Vultaggio, A, Petroni, G, Pratesi, S, Nencini, F, Maggi, E

Get full text